Answer:
Phase III
Explanation:
The given condition fall in the trial phase (Phase III) of cinical study which aims to:
- Determine drug's effectiveness (primary goal)
- Determine long-term drug safety
- Confirm findings
In Phase III, randomised, double-blind, placebo-controlled, parallel group study is majorly to evaluate the efficacy and safety of placebo in episodic migraine prevention in children (6 to < 12 years of age) and adolescents (12 to < 18 years of age).
The trial consists of four phases: screening; double-blind therapy period for 24 weeks in which placebo or Erenumab is given to subject as dose 1, dose 2 or dose 3 (based on the participant's body weight) once a month via subcutaneous injection; optional dose level blinded extension phase (40 weeks) which involves subjects recieve dose1, 2 and 3 of placebo, and at last it follows a safety follow-up phase for 12 weeks (after 16 weeks of the last dose of investigational drug).
Hence, the clinical phase is phase III.
Answer:
c
Explanation:
for me Vibration in throat
<u>ANSWER:</u>
The muscles and joints allow the hands to perform their function of holding and grasping a wide variety of things.
<u>EXPLANATION:</u>
- The structure of hands is "very delicate and complex". The tendons, nerve fibres, tissues and thin muscles are located right under the skin.
- The bones of the hand including the 4 carpal bones, 5 metacarpal and 14 finger bones are all connected by joints and ligaments and these allow the hand to grasp things.
- The wrist is made of "two parts of a joint" that allow the extension and stretching of hands.
